Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.52 |
| ▸ | MEN1 | O00255 | 1/20 | 0.34 |
| ▸ | POLB | P06746 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.34 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL36060 | 1.00 | — | — | |
| SCHEMBL27743621 | 1.00 | ALDH1A1 (0.52) | ALDH1A1MEN1POLBKMT2ANPSR1 | |
| SCHEMBL234923 | 1.00 | ALDH1A1 (0.52) | ALDH1A1MEN1POLBKMT2ANPSR1 | |
| SCHEMBL4418020 | 1.00 | ALDH1A1 (0.52) | ALDH1A1MEN1POLBKMT2ANPSR1 | |
| SCHEMBL12948617 | 1.00 | ALDH1A1 (0.52) | ALDH1A1MEN1POLBKMT2ANPSR1 | |
| SCHEMBL31315866 | 1.00 | ALDH1A1 (0.52) | ALDH1A1MEN1POLBKMT2ANPSR1 | |
| SCHEMBL9841137 | 1.00 | ALDH1A1 (0.52) | ALDH1A1MEN1POLBKMT2ANPSR1 | |
| SCHEMBL4414709 | 1.00 | ALDH1A1 (0.52) | ALDH1A1MEN1POLBKMT2ANPSR1 | |
| SCHEMBL4455914 | 0.97 | ALDH1A1 (0.50) | ALDH1A1MEN1POLBKMT2ANPSR1 | |
| SCHEMBL8204435 | 0.97 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 166 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3245256-A1 | ORGANOPOLYSILOXANE PREPOLYMER AND CURABLE ORGANOPOLYSILOXANE COMPOSITION COMPRISING SAME | Henkel AG & Co. KGaA (DE) | 2017-11-22 | — | — | EP | claimed |
| WO-2016112487-A1 | ORGANOPOLYSILOXANE PREPOLYMER AND CURABLE ORGANOPOLYSILOXANE COMPOSITION COMPRISING SAME | HENKEL (CHINA) COMPANY LIMITED (CN) | 2016-07-21 | — | — | WO | claimed |
| EP-2516569-B1 | HYDROSILYLATION REACTION INHIBITORS, AND USE THEREOF IN A COATING METHOD | BLUESTAR SILICONES FRANCE (FR) | 2016-07-20 | — | — | EP | claimed |
| US-20120328787-A1 | HYDROSILYLATION REACTION INHIBITORS, AND USE THEREOF IN A COATING METHOD | BLUESTAR SILICONES FRANCE (FR) | 2012-12-27 | — | — | US | claimed |
| EP-2516569-A1 | HYDROSILYLATION REACTION INHIBITORS, AND USE THEREOF IN A COATING METHOD | Bluestar Silicones France (FR) | 2012-10-31 | — | — | EP | claimed |
| WO-2011076710-A1 | HYDROSILYLATION REACTION INHIBITORS, AND USE THEREOF IN A COATING METHOD | BLUESTAR SILICONES FRANCE (FR) | 2011-06-30 | — | — | WO | claimed |
| EP-4714225-A1 | COMPOSITION FOR HIGH-RESILIENT THERMALLY CONDUCTIVE GAP PAD | Henkel AG & Co. KGaA (DE) | 2026-03-25 | — | — | EP | disclosed |
| EP-4240433-B1 | MEDICAL SILICONE PRESSURE-SENSITIVE ADHESIVE COMPOSITION | ELKEM SILICONES SHANGHAI CO LTD (CN) | 2025-12-24 | — | — | EP | disclosed |
| US-20250352692-A1 | MEDICAL SILICONE PRESSURE-SENSITIVE ADHESIVE COMPOSITION | ELKEM SILICONES FRANCE SAS (FR) | 2025-11-20 | — | — | US | disclosed |
| US-12453800-B2 | Medical silicone pressure-sensitive adhesive composition | ELKEM SILICONES SHANGHAI CO., LTD. (CN) | 2025-10-28 | — | — | US | disclosed |
| US-20250304576-A1 | IKK INHIBITORS | CANCER RESEARCH TECH LTD (GB) | 2025-10-02 | — | — | US | disclosed |
| WO-2025118170-A1 | THERMALLY CONDUCTIVE SILICONE ADHESIVE COMPOSITION | HENKEL AG & CO. KGAA (DE) | 2025-06-12 | — | — | WO | disclosed |
| EP-4522597-A1 | IKK INHIBITORS | Cancer Research Technology Limited (GB) | 2025-03-19 | — | — | EP | disclosed |
| US-5827883-A | TOPICAL DRUG DELIVERY; SIDE EFFECT REDUCTION | HOFFMANN-LA ROCHE INC. (US) | 1998-10-27 | — | — | US | disclosed |
| CN-1168103-A | Dermatological use of vitamin D derivs. | HOFFMANN LA ROCHE (CH) | 1997-12-17 | — | — | CN | disclosed |
| EP-0805682-A1 | DERMATOLOGICAL USE OF VITAMIN D DERIVATIVES | F. HOFFMANN-LA ROCHE AG (CH) | 1997-11-12 | — | — | EP | disclosed |
| WO-1996022776-A1 | DERMATOLOGICAL USE OF VITAMIN D DERIVATIVES | F. HOFFMANN-LA ROCHE AG (CH) | 1996-08-01 | — | — | WO | disclosed |
| US-4111917-A | POLYURETHANES | W. R. GRACE & CO. (US) | 1978-09-05 | — | — | US | disclosed |
| US-3979311-A | MIXTURE OF AN ALKYNYL CYCLOALKANOL AND AN N,N'-DICYCLOALKYL-THIOUREA | UNIVERSAL OIL PRODUCTS COMPANY (US) | 1976-09-07 | — | — | US | disclosed |
| US-3969260-A | ALKYNYL CYCLOALKANOL, N,N'-DICYCLOALKYL THIOUREA, POLYAMINOMETHYLENEPHOSPHONATE | UNIVERSAL OIL PRODUCTS COMPANY (US) | 1976-07-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250304576-A1 | IKK INHIBITORS | NFKBIA, IKBKE, IKBKB | ALDH1A1 4083/4885MEN1 2339/4885POLB 903/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.